Skip to main content
ANIMATION - GORE® EXCLUDER® AAA ENDOPROSTHESIS
GORE® EXCLUDER® AAA ENDOPROSTHESIS Learn more https://www.goremedical.com/aortic IFU https://eifu.goremedical.com
Video Player is loading.
Current Time 0:00
Duration 1:24
Loaded: 11.88%
Stream Type LIVE
Remaining Time 1:24
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

    Allows for confident endovascular repair of abdominal aortic aneurysms, with the unique ability to reconstrain the proximal end of the device and reposition it for ideal placement. 


    review-data-red

    Most studied EVAR device*

    25+ years of supporting post-trial follow-up:

    Dr. Ross Milner discusses why continued studies are helping advance aortic treatment.

    Update on five-year EVAR outcomes from GREAT
    Video featuring Ross Milner, M.D. reviewing EVAR outcomes from GREAT
    Video Player is loading.
    Current Time 0:00
    Duration 4:41
    Loaded: 3.55%
    Stream Type LIVE
    Remaining Time 4:41
     
    1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
      Peer-reviewed RTB video
      Short video created to communicate volume of peer-reviewed articles resulting from GREAT Registry Study, featuring audio from Dr. Milner
      Video Player is loading.
      Current Time 0:00
      Duration 0:30
      Loaded: 32.35%
      Stream Type LIVE
      Remaining Time 0:30
       
      1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • en (Main), selected

        content-creation-red

        Over 1,500 peer-reviewed publications

        25+ years of peer-reviewed publications:

        how one registry continues to contribute EVAR insights through literature. 


        nurse-red

        490,000+ patients treated worldwide

        25+ years of advancing patient care:

        One man shares how the continued innovation of the EXCLUDER® Device family made a difference in his life.

        Patient testimonial - seven years post treatment
        Video Player is loading.
        Current Time 0:00
        Duration 4:44
        Loaded: 3.49%
        Stream Type LIVE
        Remaining Time 4:44
         
        1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
        • en (Main), selected

          The next generation in aortic accessories 
           

          Related to this product


          * Based on company-sponsored trials and registries shown on clinicaltrials.gov for currently available stent grafts. 
          Based on the number of Trunk-Ipsilateral Legs distributed. 


          IFU Consult instructions

          Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly 

          INDICATIONS FOR USE IN THE U.S.: Trunk-Ipsilateral Leg and Contralateral Leg Endoprosthesis. The GORE® EXCLUDER® AAA Endoprosthesis is intended to exclude the aneurysm from the blood circulation in patients diagnosed with infrarenal abdominal aortic aneurysm (AAA) disease and who have appropriate anatomy as described below: Adequate iliac/femoral access; Infrarenal aortic neck treatment diameter range of 19–32 mm and a minimum aortic neck length of 15 mm; Proximal aortic neck angulation ≤ 60°; Iliac artery treatment diameter range of 8–25 mm and iliac distal vessel seal zone length of at least 10 mm. Aortic Extender and Iliac Extender Endoprosthesis. The Aortic and Iliac Extender Endoprostheses are intended to be used after deployment of the GORE® EXCLUDER® AAA Endoprosthesis. These extensions are intended to be used when additional length and/or sealing for aneurysmal exclusion is desired.  

          CONTRAINDICATIONS: The GORE® EXCLUDER® AAA Endoprosthesis is contraindicated in: patients with known sensitivities or allergies to the device materials; patients with a systemic infection who may be at increased risk of endovascular graft infection. 

          Products listed may not be approved in all markets.